简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

MAIA Biotechnology宣布74万美元私募

2025-10-14 04:45

  • MAIA Biotechnology (NYSE:MAIA) announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 0.60M shares of common stock at a purchase price of $1.22 per share in a private placement offering gross proceeds of $0.74M to authorized investors.
  • Each common share will be issued with a warrant to buy one share at a price of $1.52 per share, in line with the NYSE minimum price requirement.
  • The net proceeds from the offering will be used to fund the execution of Step 1 of Part C of the Phase II trial THIO-101 and for working capital.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。